Page 41 - Registration Document News Today

PRESS RELEASE Lyon, September 13, 2023 ADOCIA Announces the Availability of a Prospectus for the Admission to Trading of Shares Issued or...

LYON, France--(BUSINESS WIRE)--#BIOTECH--Regulatory News:Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity (the “Company”), announces today the availability of...

Clichy, France, September 11, 2023...

51% increase in Sibnayal® gross sales to €0.96 millionSignificant reduction in operating losses to €2.9 million (vs. €4.4 million in H1 2022)€0.9 million improvement in cash flow from operationsCash position of €3.42 millionCompletion of European marketing coverage for Sibnayal®Launch of a capital increase with pref...

Press Release 7 September 2023 - N° 17 SCOR launches its new strategic plan “Forward 2026” Driving...

Please note that the conference call was accompanied by a complementary presentation in PDF format available on the Groups website: http://www.coface.com/Investors,under the Financial...

Please note that the conference call was accompanied by a complementary presentation in PDF format available on the Groups website: http://www.coface.com/Investors,under the Financial...

Final version .pdf

Lille , Cambridge , Zurich , September 05, 2023 – GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced...

Daix , Long Island City , August 31, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with...